Smith DC - Search Results

1

Phase II trial of paclitaxel and carboplatin in the treatment of advanced urothelial carcinoma.

Redman BG, Smith DC, Flaherty L, Du W, Hussain M. Redman BG, et al. Among authors: smith dc. J Clin Oncol. 1998 May;16(5):1844-8. doi: 10.1200/JCO.1998.16.5.1844. J Clin Oncol. 1998. PMID: 9586899 Clinical Trial.

2

Megestrol acetate in the treatment of hormone refractory prostate cancer.

Osborn JL, Smith DC, Trump DL. Osborn JL, et al. Among authors: smith dc. Am J Clin Oncol. 1997 Jun;20(3):308-10. doi: 10.1097/00000421-199706000-00021. Am J Clin Oncol. 1997. PMID: 9167760

3

A phase II trial of oral estramustine and oral etoposide in hormone refractory prostate cancer.

Pienta KJ, Redman BG, Bandekar R, Strawderman M, Cease K, Esper PS, Naik H, Smith DC. Pienta KJ, et al. Among authors: smith dc. Urology. 1997 Sep;50(3):401-6; discussion 406-7. doi: 10.1016/S0090-4295(97)00228-8. Urology. 1997. PMID: 9301705 Clinical Trial.

4

Paclitaxel, estramustine, and etoposide in the treatment of hormone-refractory prostate cancer.

Pienta KJ, Smith DC. Pienta KJ, et al. Among authors: smith dc. Semin Oncol. 1997 Oct;24(5 Suppl 15):S15-72-S15-77. Semin Oncol. 1997. PMID: 9346227 Clinical Trial.

5

Change in serum prostate-specific antigen as a marker of response to cytotoxic therapy for hormone-refractory prostate cancer.

Smith DC, Dunn RL, Strawderman MS, Pienta KJ. Smith DC, et al. J Clin Oncol. 1998 May;16(5):1835-43. doi: 10.1200/JCO.1998.16.5.1835. J Clin Oncol. 1998. PMID: 9586898 Clinical Trial.

6

A phase II trial of oral diethylstilbesterol as a second-line hormonal agent in advanced prostate cancer.

Smith DC, Redman BG, Flaherty LE, Li L, Strawderman M, Pienta KJ. Smith DC, et al. Urology. 1998 Aug;52(2):257-60. doi: 10.1016/s0090-4295(98)00173-3. Urology. 1998. PMID: 9697791 Clinical Trial.

7

Carmustine and streptozocin in refractory melanoma: an attempt at modulation of O-alkylguanine-DNA-alkyltransferase.

Smith DC, Gerson SL, Liu L, Donnelly S, Day R, Trump DL, Kirkwood JM. Smith DC, et al. Clin Cancer Res. 1996 Jul;2(7):1129-34. Clin Cancer Res. 1996. PMID: 9816278 Clinical Trial.

8

Paclitaxel in the treatment of hormone-refractory prostate cancer.

Smith DC, Pienta KJ. Smith DC, et al. Semin Oncol. 1999 Feb;26(1 Suppl 2):109-11. Semin Oncol. 1999. PMID: 10190791 Review.

9

A Phase I trial of calcitriol (1,25-dihydroxycholecalciferol) in patients with advanced malignancy.

Smith DC, Johnson CS, Freeman CC, Muindi J, Wilson JW, Trump DL. Smith DC, et al. Clin Cancer Res. 1999 Jun;5(6):1339-45. Clin Cancer Res. 1999. PMID: 10389917 Clinical Trial.

10

Phase II trial of oral estramustine, oral etoposide, and intravenous paclitaxel in hormone-refractory prostate cancer.

Smith DC, Esper P, Strawderman M, Redman B, Pienta KJ. Smith DC, et al. J Clin Oncol. 1999 Jun;17(6):1664-71. doi: 10.1200/JCO.1999.17.6.1664. J Clin Oncol. 1999. PMID: 10561202 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,042 results

Search Page

Filters